Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Naturally occurring salivary antifungal proteins have been of major interest, due to their potential to provide the basis for peptide antimycotics effective in combating fungal infections in the oral cavity or elsewhere. We tested the fungistatic activity of a number of cationic antifungal proteins, with major emphasis on histatin 5, a basic protein secreted by the human parotid and submandibular glands. Histatin 5 inhibited the growth of Candida albicans and that of other medically important Candida species, such as C. kefyr, C. krusei, and C. parapsilosis, with IC 50 values in the range of 10–20 µg/ml. Two Cryptococcus neoformans strains were also sensitive (IC 50 5.2 and 5.6 µg/ml). On the other hand, three C. glabrata strains (ATCC 90030, 2001 and 64677) were entirely insensitive to histatin 5 (IC 50>225 µg/ml). Four genetically very similar species to C. glabrata, Candida castelli (CBS 4332), Saccharomyces cerevisiae (S288C, BY4741 and CBS 1171), Kluyveromyces delphensis (CBS 2170) and Kluyveromyces bacillisporus (CBS 7720) were all sensitive to histatin 5 (IC 50 2.6–64.6 µg/ml). C. glabrata was also insensitive to other members of the histatin family; histatin 1, 3 and P‐113 (IC 50 values in all cases >225 µg/ml). In addition, two entirely different cationic antifungal proteins originating from frog skin, PGLa and magainin 2, also showed a strong reduced activity toward this fungus. Besides the well‐described inherent resistance of C. glabrata to azole‐derived antifungal agents, our studies indicate that this species is also able to withstand the otherwise detrimental activities of cationic antifungal proteins. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285
Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217 · cited 1×
“Otherwise, it can be hypothesized that the capacity of C. glabrata to upregulate the expression of the drug efflux pumps encoded by CDR1 and PDH1 (Bennett et al., 2004; Vermitsky and Edlind, 2004) may also negatively affect the efficacy and intracellular accumulation of cationic proteins.”
BackgroundPfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3137-3141.2004 · Cited by 66
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata
DEFONTAINE, A., BOUCHARA, J.-P., DECLERK, P., PLANCHENAULT, C., CHABASSE, D., & HALLET, J.-N. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-7-663 · Cited by 65 · cited 1×
“For example, in a few studies, fluconazole-resistant C. glabrata strains were found to be of the ‘petite’ phenotype (Defontaine et al., 1999; Brun et al., 2003) and similar ‘petite’ mutations in C. albicans are known to confer resistance to histatins (Gyurko et al., 2000).”
ResultRelationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata
Brun, S., Aubry, C., Lima, O., Filmon, R., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.847-853.2003 · Cited by 64 · cited 1×
“For example, in a few studies, fluconazole-resistant C. glabrata strains were found to be of the ‘petite’ phenotype (Defontaine et al., 1999; Brun et al., 2003) and similar ‘petite’ mutations in C. albicans are known to confer resistance to histatins (Gyurko et al., 2000).”
Result
Cited by
Helmerhorst, E. J., & Oppenheim, F. G. (2007) · Journal of Dental Research · doi:10.1177/154405910708600802 · Cited by 330
Self-citationAdvances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Roscetto, E., Contursi, P., Vollaro, A., Fusco, S., Notomista, E., & Catania, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35530-0 · Cited by 272
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Susceptibility of Candida biofilms to histatin 5 and fluconazole
Konopka, K., Dorocka-Bobkowska, B., Gebremedhin, S., & Düzgüneş, N. (2010) · Antonie van Leeuwenhoek · doi:10.1007/s10482-010-9417-5 · Cited by 48
“Very high resistance of C. glabrata to histatin 5, with IC50 values over 225 lg/ml (74.0 lM), was also observed ( Helmerhorst et al. 2005 ).”
BackgroundInfluential
Metadata
- Authors
- Helmerhorst, E. J., Venuleo, C., Beri, A., & Oppenheim, F. G.
- Venue
- Yeast
- Publisher
- Wiley
- Published
- 2005-07-15
- Volume
- 22
- Issue
- 9
- Pages
- 705-714
- ISSN
- 0749-503X (ISSN-L)
- 1097-0061
- OpenAlex
- W2156356388
- Cited by
- 53
- References
- 6
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. https://app.cochat.ai/papers/10.1002/yea.1241
- The paper
- Helmerhorst, E. J., Venuleo, C., Beri, A., & Oppenheim, F. G. (2005). Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast. https://doi.org/10.1002/yea.1241
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.